MOC — Molecure SA Balance Sheet
0.000.00%
- PLN173.75m
- PLN162.79m
- PLN2.17m
Annual balance sheet for Molecure SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | Interim Report | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 121 | 102 | 65.6 | 64 | 18.2 |
Net Total Receivables | 9.39 | 13.4 | 8.43 | 0.855 | 31.5 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 130 | 116 | 75 | 65.7 | 50.3 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 7.89 | 10 | 11.6 | 10.6 | 9.49 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 153 | 152 | 138 | 112 | 114 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6.61 | 6.16 | 6.98 | 6.04 | 5.12 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 10.1 | 10.4 | 11.6 | 11.3 | 10.3 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 143 | 141 | 126 | 101 | 103 |
Total Liabilities & Shareholders' Equity | 153 | 152 | 138 | 112 | 114 |
Total Common Shares Outstanding |